Literature DB >> 31392246

An Evaluation of the Progressive Supranuclear Palsy Speech/Language Variant.

Jennifer L Whitwell1, Chase A Stevens2,3, Joseph R Duffy2, Heather M Clark2, Mary M Machulda4, Edythe A Strand2, Peter R Martin5, Rene L Utianski2, Hugo Botha2, Anthony J Spychalla1, Matthew L Senjem1,6, Christopher G Schwarz1, Clifford R Jack1, Farwa Ali2, Anhar Hassan2, Keith A Josephs2.   

Abstract

BACKGROUND: The Movement Disorder Society clinical criteria for progressive supranuclear palsy (PSP) provide a framework for assessing the presence/severity of clinical symptoms and define a speech/language variant of PSP.
OBJECTIVES: To evaluate the clinical criteria in a cohort of speech/language patients with longitudinal follow-up.
METHODS: A total of 52 patients presenting with progressive apraxia of speech and/or agrammatic aphasia were followed longitudinally for up to 6 visits with clinical assessments and magnetic resonance imaging. We assessed oculomotor, postural instability, and akinesia diagnostic levels and determined whether patients met criteria for possible PSP-speech/language or probable PSP at each visit. Kaplan-Meier curves assessed time-to-event probabilities according to age. Statistical parametric mapping and midbrain volume were assessed according to disease progression.
RESULTS: Few PSP symptoms were observed early in the disease, with oculomotor abnormalities and falls first observed 2 years after onset. Falls were more common than vertical supranuclear gaze palsy. Bradykinesia and rigidity commonly developed but axial was rarely greater than appendicular rigidity. During follow-up, 54% met criteria for possible PSP-speech/language, 38% for probable PSP-Richardson's syndrome, and 38% for probable PSP-parkinsonism, most commonly 6 to 6.9 years after onset. The probability of developing PSP was greater when onset was at an age older than 70 years. Patients who progressed to probable PSP had more parkinsonism and oculomotor impairment at baseline and greater midbrain atrophy when compared with those who did not develop probable PSP.
CONCLUSIONS: Symptoms typical of PSP commonly develop in patients presenting with a progressive speech/language disorder. Older age appears to be an important prognostic factor in these patients.

Entities:  

Keywords:  PSP; agrammatism; aphasia; apraxia of speech; midbrain

Year:  2019        PMID: 31392246      PMCID: PMC6660227          DOI: 10.1002/mdc3.12796

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  29 in total

Review 1.  Voxel-based morphometry--the methods.

Authors:  J Ashburner; K J Friston
Journal:  Neuroimage       Date:  2000-06       Impact factor: 6.556

2.  Unified segmentation.

Authors:  John Ashburner; Karl J Friston
Journal:  Neuroimage       Date:  2005-04-01       Impact factor: 6.556

3.  Neuropathology of progressive supranuclear palsy.

Authors:  Dennis W Dickson
Journal:  Handb Clin Neurol       Date:  2008

4.  Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia.

Authors:  K A Josephs; B F Boeve; J R Duffy; G E Smith; D S Knopman; J E Parisi; R C Petersen; D W Dickson
Journal:  Neurocase       Date:  2005-08       Impact factor: 0.881

5.  A clinical rating scale for progressive supranuclear palsy.

Authors:  Lawrence I Golbe; Pamela A Ohman-Strickland
Journal:  Brain       Date:  2007-04-02       Impact factor: 13.501

6.  Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech.

Authors:  Keith A Josephs; Joseph R Duffy; Edyth A Strand; Jennifer L Whitwell; Kenneth F Layton; Joseph E Parisi; Mary F Hauser; Robert J Witte; Bradley F Boeve; David S Knopman; Dennis W Dickson; Clifford R Jack; Ronald C Petersen
Journal:  Brain       Date:  2006-04-13       Impact factor: 13.501

7.  Prediction of pathology in primary progressive language and speech disorders.

Authors:  V Deramecourt; F Lebert; B Debachy; M A Mackowiak-Cordoliani; S Bombois; O Kerdraon; L Buée; C-A Maurage; F Pasquier
Journal:  Neurology       Date:  2009-11-25       Impact factor: 9.910

8.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Authors:  Christopher G Goetz; Barbara C Tilley; Stephanie R Shaftman; Glenn T Stebbins; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Matthew B Stern; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J van Hilten; Nancy LaPelle
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

9.  Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.

Authors:  David R Williams; Rohan de Silva; Dominic C Paviour; Alan Pittman; Hilary C Watt; Linda Kilford; Janice L Holton; Tamas Revesz; Andrew J Lees
Journal:  Brain       Date:  2005-03-23       Impact factor: 13.501

10.  Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy.

Authors:  David R Williams; Janice L Holton; Kate Strand; Tamas Revesz; Andrew J Lees
Journal:  Mov Disord       Date:  2007-11-15       Impact factor: 10.338

View more
  15 in total

1.  Ioflupane 123I (DAT scan) SPECT identifies dopamine receptor dysfunction early in the disease course in progressive apraxia of speech.

Authors:  Zeynep Idil Seckin; Jennifer L Whitwell; Rene L Utianski; Hugo Botha; Farwa Ali; Joseph R Duffy; Heather M Clark; Mary M Machulda; Lennon G Jordan; Hoon-Ki Min; Val J Lowe; Keith A Josephs
Journal:  J Neurol       Date:  2020-05-09       Impact factor: 4.849

2.  Autopsy Validation of Progressive Supranuclear Palsy-Predominant Speech/Language Disorder Criteria.

Authors:  Fatma Ozlem Hokelekli; Joseph R Duffy; Heather M Clark; Rene L Utianski; Hugo Botha; Farwa Ali; Julie A Stierwalt; Mary M Machulda; R Ross Reichard; Dennis W Dickson; Jennifer L Whitwell; Keith A Josephs
Journal:  Mov Disord       Date:  2021-10-10       Impact factor: 10.338

3.  Differences in aphasia syndromes between progressive supranuclear palsy-Richardson's syndrome, behavioral variant frontotemporal dementia and Alzheimer's dementia.

Authors:  Lucia Ransmayr; Alexandra Fuchs; Sibylle Ransmayr-Tepser; Romana Kommenda; Mariella Kögl; Petra Schwingenschuh; Franz Fellner; Michael Guger; Christian Eggers; Robert Darkow; Stephanie Mangesius; Gerhard Ransmayr
Journal:  J Neural Transm (Vienna)       Date:  2022-07-12       Impact factor: 3.850

4.  Survival Analysis in Primary Progressive Apraxia of Speech and Agrammatic Aphasia.

Authors:  Jennifer L Whitwell; Peter Martin; Joseph R Duffy; Heather M Clark; Rene L Utianski; Hugo Botha; Mary M Machulda; Edythe A Strand; Keith A Josephs
Journal:  Neurol Clin Pract       Date:  2021-06

5.  The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study.

Authors:  Zeynep Idil Seckin; Joseph R Duffy; Edythe A Strand; Heather M Clark; Rene L Utianski; Mary M Machulda; Hugo Botha; Farwa Ali; Nha Trang Thu Pham; Val J Lowe; Jennifer L Whitwell; Keith A Josephs
Journal:  Parkinsonism Relat Disord       Date:  2020-10-07       Impact factor: 4.891

6.  Primary Progressive Apraxia of Speech: From Recognition to Diagnosis and Care.

Authors:  Joseph R Duffy; Rene L Utianski; Keith A Josephs
Journal:  Aphasiology       Date:  2020-07-07       Impact factor: 2.773

7.  Motor Speech Disorders and Communication Limitations in Progressive Supranuclear Palsy.

Authors:  Heather M Clark; Rene L Utianski; Farwa Ali; Hugo Botha; Jennifer L Whitwell; Keith A Josephs
Journal:  Am J Speech Lang Pathol       Date:  2021-03-09       Impact factor: 2.408

8.  A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech.

Authors:  Keith A Josephs; Joseph R Duffy; Heather M Clark; Rene L Utianski; Edythe A Strand; Mary M Machulda; Hugo Botha; Peter R Martin; Nha Trang Thu Pham; Julie Stierwalt; Farwa Ali; Marina Buciuc; Matthew Baker; Cristhoper H Fernandez De Castro; Anthony J Spychalla; Christopher G Schwarz; Robert I Reid; Matthew L Senjem; Clifford R Jack; Val J Lowe; Eileen H Bigio; Ross R Reichard; Eric J Polley; Nilufer Ertekin-Taner; Rosa Rademakers; Michael A DeTure; Owen A Ross; Dennis W Dickson; Jennifer L Whitwell
Journal:  Nat Commun       Date:  2021-06-08       Impact factor: 17.694

Review 9.  Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies.

Authors:  Maria Stamelou; Gesine Respondek; Nikolaos Giagkou; Jennifer L Whitwell; Gabor G Kovacs; Günter U Höglinger
Journal:  Nat Rev Neurol       Date:  2021-08-23       Impact factor: 42.937

10.  Sleep disturbances in the speech-language variant of progressive supranuclear palsy.

Authors:  Fatma Ozlem Hokelekli; Farwa Ali; Arenn F Carlos; Peter R Martin; Heather M Clark; Joseph R Duffy; Rene L Utianski; Hugo Botha; Erik K St Louis; Jennifer L Whitwell; Keith A Josephs
Journal:  Parkinsonism Relat Disord       Date:  2021-08-18       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.